Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.2B
133M shares
52-week range
$10.34 – $19.25
65% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
P/S (TTM)
6.9
EV / FCF (TTM)
11.7
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
www.auriniapharma.comNo one on the platform currently holds AUPH.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,663,835 | $24.7M |
No one on the platform has traded AUPH yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 45.8% | — | — | — | ||
| Rev. Growth % | 20.4% | 41.4% | ||||
| Profit Margin % | 101.5% | -83.6% | -7258.6% | |||
| Free Cash Flow Margin % | 47.8% | -72.3% | -5234.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +9.6% on the P/E track.
At today's price, your expected annual return is +15.9% on the P/E track.
At today's price, your expected annual return is +23.5% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $330M | +17.7% | $0.94 | $0.77–$1.02 | 17.1× | 4 |
| 2027 | $388M | +17.6% | $1.18 | $0.68–$1.46 | 13.7× | 5 |
| 2028 | $447M | +15.1% | $1.44 | $0.52–$2.67 | 11.2× | 5 |
| 2029 | $472M | +5.5% | $1.66 | $1.57–$1.89 | 9.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.24 | $0.28 | +16.7% |
| 2026-05-07 | $0.18 | $0.25 | +38.9% |
| 2026-02-26 | $0.21 | $0.26 | +23.8% |
| 2025-11-04 | $0.16 | $0.23 | +43.8% |
| 2025-07-31 | $0.17 | $0.16 | -5.9% |
| 2025-05-12 | $0.08 | $0.16 | +100.0% |
| 2025-02-27 | $0.03 | $0.01 | -66.7% |
| 2024-11-07 | $0.02 |
| $0.10 |
| +400.0% |
| $2.4B |
| — |
| IMCRImmunocore Holdings plc | $32.46 | -0.43% | $1.7B | — |
| JANXJanux Therapeutics, Inc. | $17.31 | +1.23% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
$AUPH Yesterday up .31 cents. Today down .31 cents. Just no love!
View on StockTwits ↗
Out of the tightness the $PRAA lolly should $FLNG it like a 🧠. At least they $AUPH TTWO
View on StockTwits ↗
$AUPH I'm doing laundry. My washing machine sounds like, "Tonight's the night, tonight's the night, etc."Hahaha wishful thinking!
View on StockTwits ↗
$AUPH We continue as a dramamine company, up/down. Sure would be nice to finally receive that buyout we are all waiting for.!
View on StockTwits ↗
$AUPH Another "Thankful Tuesday" in Auphyland - we woke up 🙏🙏🙏
View on StockTwits ↗
$AUPH $AUPH glad I sold some yesterday this junk always disappoints until Tang figures out his end game
View on StockTwits ↗
$AUPH like a rubber - the complete yesterday is gone...😂
View on StockTwits ↗
$AUPH Yup VERA selling off and we are going up.
View on StockTwits ↗$AUPH may we are some time behind - but at least a monthly vs. a weekly s.c. needle should make a difference too... time is tickin VERA...
View on StockTwits ↗$AUPH Either people can jump in overbloated VERA or they can realize that dual BAFF+APRIL blockers are gonna be alpha omega in inflammatory diseases and jump in Aurinia early. Once market opens up I have a feeling VERA is gonna start selling off and we are gonna get that volume.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.